| Fibrohistiocytic Neoplasm studied in …STUDIED_INderived10 of 23show all (up to 200) |
|---|
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ALIAS · 23 trials mapped (6 active) | — | — | Giant Cell Tumor of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07707882Phase 2 · not yet recruiting Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell Tumor · condition mapped ALIAS · 23 trials mapped (6 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03069469Phase 1/Phase 2 · active not recruiting Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor · condition mapped ALIAS · 23 trials mapped (6 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02180867Phase 2/Phase 3 · completed Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 23 trials mapped (6 active) | — | — | Fibrohistiocytic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05804045Phase 3 · active not recruiting Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER) · condition mapped ALIAS · 23 trials mapped (6 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059262Phase 3 · active not recruiting Study of Vimseltinib for Tenosynovial Giant Cell Tumor · condition mapped ALIAS · 23 trials mapped (6 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01207492Phase 2 · completed Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor · condition mapped ALIAS · 23 trials mapped (6 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06387485NA · recruiting A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning · condition mapped ONTOLOGY_EXACT · 23 trials mapped (6 active) | — | — | Fibrous Histiocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05349643Phase 2 · completed A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT · condition mapped ALIAS · 23 trials mapped (6 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04731675Phase 2 · completed An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee · condition mapped ALIAS · 23 trials mapped (6 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |